methylene blue has been researched along with n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okada, Y; Taira, N; Yanagisawa, T | 1 |
| Izawa, T; Izumi, H; Jinno, Y; Ogawa, N; Okada, Y; Yokoyama, T | 1 |
| Fukata, Y; Fukushima, H; Harada, K; Kasai, H; Ogawa, N | 1 |
| Fukata, Y; Fukushima, H; Jinno, Y; Kaneta, S; Ogawa, N; Okada, Y; Yokoyama, T | 1 |
| Chiba, S; Horiuchi, A; Iwatsuki, K; Ren, LM | 1 |
| Fukata, Y; Fukushima, H; Jinno, Y; Kaneta, S; Miwa, A; Ogawa, N | 1 |
| Okamoto, K; Sakuta, H; Watanabe, Y | 1 |
| Gambino, A; Thomas, BJ; Wanstall, JC | 1 |
8 other study(ies) available for methylene blue and n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate
| Article | Year |
|---|---|
An analysis of the nitrate-like and K channel opening actions of KRN2391 in canine coronary arterial smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Antihypertensive Agents; Calcium; Coronary Vessels; Dogs; Female; Glyburide; In Vitro Techniques; Male; Methylene Blue; Muscle Contraction; Muscle, Smooth, Vascular; Nitrates; Potassium Channels; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Pyridines; Vasodilation | 1991 |
Comparative analysis of vasodilating mechanisms of Ki1769, Ki3315 and KRN2391, pyridinecarboximidamide derivatives, in porcine isolated coronary artery.
Topics: Animals; Coronary Vessels; Cyclic GMP; Glyburide; In Vitro Techniques; Methylene Blue; Potassium Channels; Pyridines; Swine; Vasodilation; Vasodilator Agents | 1994 |
Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
Topics: Animals; Benzopyrans; Cromakalim; Dogs; Female; Glyburide; In Vitro Techniques; Male; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nitrates; Potassium Channels; Potassium Chloride; Pyridines; Pyrroles; Renal Artery; Vasodilator Agents | 1993 |
Mechanism of action of KRN2391 in canine coronary vascular bed.
Topics: Animals; Antihypertensive Agents; Arteries; Benzopyrans; Coronary Circulation; Coronary Vessels; Cromakalim; Dogs; Drug Interactions; Female; Glyburide; In Vitro Techniques; Male; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Pyridines; Pyrroles; Vasodilator Agents | 1993 |
Effects of KRN2391, a novel vasodilator, on pancreatic exocrine secretion in anesthetized dogs.
Topics: Animals; Bicarbonates; Cyclic AMP; Cyclic GMP; Dogs; Female; Guanidines; Male; Methylene Blue; Nitroprusside; Pancreas; Pancreatic Juice; Pinacidil; Proteins; Pyridines; Secretin; Sincalide; Vasodilator Agents | 1993 |
Mechanism of action of KRN2391, a novel vasodilator, in canine mesenteric artery.
Topics: Animals; Arterioles; Benzopyrans; Cromakalim; Dogs; Female; Glyburide; In Vitro Techniques; Male; Mesenteric Arteries; Methylene Blue; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Pyridines; Pyrroles; Splanchnic Circulation; Vascular Resistance; Vasodilator Agents | 1993 |
Modification by cGMP of glibenclamide-sensitive K+ currents in Xenopus oocytes.
Topics: Animals; Benzopyrans; Cromakalim; Cyclic GMP; Female; Glyburide; In Vitro Techniques; Membrane Potentials; Methylene Blue; Niacinamide; Nicorandil; Nitroprusside; Oocytes; Potassium Channels; Pyridines; Pyrroles; Xenopus laevis | 1993 |
KRN2391: dual action on rat pulmonary artery and no loss of potency in pulmonary hypertension.
Topics: Adenosine Triphosphate; Animals; Cromakalim; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Guanylate Cyclase; Humans; Hypertension, Pulmonary; Hypoglycemic Agents; In Vitro Techniques; Infant, Newborn; Male; Methylene Blue; Molsidomine; Nitric Oxide Donors; Potassium Channels; Pulmonary Artery; Pyridines; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 2000 |